Literature DB >> 23149576

Class-IA phosphoinositide 3-kinase p110β Triggers GPCR-induced superoxide production in p110γ-deficient murine neutrophils.

Kiyomi Nigorikawa1, Kaoru Hazeki, Takashi Kumazawa, Yuhta Itoh, Megumi Hoshi, Osamu Hazeki.   

Abstract

Studies with knockout mice have indicated that the only isoform of phosphoinositide 3-kinase (PI3K) functioning in the oxidative burst of mouse neutrophils in response to heterotrimeric guanine nucleotide-binding protein-coupled receptor (GPCR) agonists is a class-IB PI3K, p110γ. In the present study, we observed that the cells from p110γ(-/-) mice gain a response to N-formyl-Met-Leu-Phe (fMLP) after priming with cytochalasin E. Even the unprimed cells, which show no response to fMLP, produce a significant amount of superoxide, when an effective agonist of the mouse-type fMLP receptors, Trp-Lys-Tyr-Met-Val-D-Met, is used to stimulate the cells. These results suggested that the class-IA isoforms (p110α, p110β, and p110δ) of PI3K are sufficient to trigger and maintain superoxide production. Examination of the effects of isoform-specific inhibitors suggested that the p110β isoform is the primary PI3K triggering the response to GPCR agonists when p110γ is absent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23149576     DOI: 10.1254/jphs.12134fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  2 in total

Review 1.  PI3Kβ-A Versatile Transducer for GPCR, RTK, and Small GTPase Signaling.

Authors:  Anne R Bresnick; Jonathan M Backer
Journal:  Endocrinology       Date:  2019-03-01       Impact factor: 4.736

2.  Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory Responses During Influenza A H1N1 Infection: From Murine Model to Genetic Association in Patients.

Authors:  Cristiana C Garcia; Luciana P Tavares; Ana Carolina F Dias; Fernanda Kehdy; Lucia Elena Alvarado-Arnez; Celso M Queiroz-Junior; Izabela Galvão; Braulio H Lima; Aline R Matos; Ana Paula F Gonçalves; Frederico M Soriani; Milton O Moraes; João T Marques; Marilda M Siqueira; Alexandre M V Machado; Lirlândia P Sousa; Remo C Russo; Mauro M Teixeira
Journal:  Front Immunol       Date:  2018-05-15       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.